BACKGROUND: The number of gastric bypass operations being performed is increasing rapidly due to good weight loss and alleviation of comorbidities in combination with low mortality and morbidity. Stomal ulcers are, however, a clinical problem after gastric bypass, giving patients discomfort, risk of bleeding, or even perforation. To measure the acidity in the proximal jejunum, we adopted the wireless pH-metry (BRAVO™ system) developed for evaluating reflux esophagitis. METHODS: Twenty-five patients (4 men; median age, 44 years; body mass index, 29.3) who had undergone Roux-en-Y gastric bypass (RYGBP) 4 years earlier were recruited. Twenty-one asymptomatic, non-proton pump inhibitor (PPI) users, and in addition, four symptomatic patients (ongoing or stopped PPI treatment) were studied. The wireless BRAVO™ capsule was positioned at the level of the gastrojejunal anastomosis under visual control with the endoscope. pH was registered for up to 48 h. Time with pH<4 was calculated. Two patients were studied with two capsules. RESULTS: Of the 25 recruited patients, capsule placement was successful in all but two patients, and in three patients a constant neutral environment was seen before a premature loss of signal, indicating early loss of position. Thus, 20 successful measurements were made. The mean time of registration was 25.7 (range, 6.1-47.4) h (n=20). In the 16 asymptomatic patients, median percentage of time with pH<4 at the gastrojejunostomy was 10.5% (range, 0.4-37.7%). When dividing the registration time in day (06.00-22.00) and night (22.00-06.00), the median percentage of time with pH<4 was 8.4 and 6.3, respectively (p=0.08). The two double measurements gave similar results indicating consistency. No complications occurred. CONCLUSIONS: Wireless pH measurements in the proximal jejunum after gastric bypass are feasible and safe. The acidity was significant (10.5% of the registration time) even in asymptomatic patients with small gastric pouches. The described method could be useful in evaluation of epigastralgia after gastric bypass and in appraisal of PPI treatment of stomal ulcer.
BACKGROUND: The number of gastric bypass operations being performed is increasing rapidly due to good weight loss and alleviation of comorbidities in combination with low mortality and morbidity. Stomal ulcers are, however, a clinical problem after gastric bypass, giving patients discomfort, risk of bleeding, or even perforation. To measure the acidity in the proximal jejunum, we adopted the wireless pH-metry (BRAVO™ system) developed for evaluating reflux esophagitis. METHODS: Twenty-five patients (4 men; median age, 44 years; body mass index, 29.3) who had undergone Roux-en-Y gastric bypass (RYGBP) 4 years earlier were recruited. Twenty-one asymptomatic, non-proton pump inhibitor (PPI) users, and in addition, four symptomatic patients (ongoing or stopped PPI treatment) were studied. The wireless BRAVO™ capsule was positioned at the level of the gastrojejunal anastomosis under visual control with the endoscope. pH was registered for up to 48 h. Time with pH<4 was calculated. Two patients were studied with two capsules. RESULTS: Of the 25 recruited patients, capsule placement was successful in all but two patients, and in three patients a constant neutral environment was seen before a premature loss of signal, indicating early loss of position. Thus, 20 successful measurements were made. The mean time of registration was 25.7 (range, 6.1-47.4) h (n=20). In the 16 asymptomatic patients, median percentage of time with pH<4 at the gastrojejunostomy was 10.5% (range, 0.4-37.7%). When dividing the registration time in day (06.00-22.00) and night (22.00-06.00), the median percentage of time with pH<4 was 8.4 and 6.3, respectively (p=0.08). The two double measurements gave similar results indicating consistency. No complications occurred. CONCLUSIONS: Wireless pH measurements in the proximal jejunum after gastric bypass are feasible and safe. The acidity was significant (10.5% of the registration time) even in asymptomatic patients with small gastric pouches. The described method could be useful in evaluation of epigastralgia after gastric bypass and in appraisal of PPI treatment of stomal ulcer.
Authors: S Jay Olshansky; Douglas J Passaro; Ronald C Hershow; Jennifer Layden; Bruce A Carnes; Jacob Brody; Leonard Hayflick; Robert N Butler; David B Allison; David S Ludwig Journal: N Engl J Med Date: 2005-03-17 Impact factor: 91.245
Authors: José María Remes-Troche; Jorge Ibarra-Palomino; Ramon I Carmona-Sánchez; Miguel A Valdovinos Journal: Am J Gastroenterol Date: 2005-11 Impact factor: 10.864
Authors: Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal Journal: JAMA Date: 2006-04-05 Impact factor: 56.272
Authors: Louise Ladebo; Pernille V Pedersen; Grzegorz J Pacyk; Jens Peter Kroustrup; Asbjørn M Drewes; Christina Brock; Anne E Olesen Journal: Obes Surg Date: 2021-03-12 Impact factor: 4.129
Authors: Usha K Coblijn; Amin B Goucham; Sjoerd M Lagarde; Sjoerd D Kuiken; Bart A van Wagensveld Journal: Obes Surg Date: 2014-02 Impact factor: 4.129
Authors: A S Darwich; D Pade; K Rowland-Yeo; M Jamei; A Asberg; H Christensen; D M Ashcroft; A Rostami-Hodjegan Journal: CPT Pharmacometrics Syst Pharmacol Date: 2013-06-12
Authors: Konstantinos Arapis; Jean Baptiste Cavin; Laura Gillard; Françoise Cluzeaud; Philippe Lettéron; Robert Ducroc; Johanne Le Beyec; Muriel Hourseau; Anne Couvelard; Jean-Pierre Marmuse; Maude Le Gall; André Bado Journal: PLoS One Date: 2015-03-30 Impact factor: 3.240